BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27105280)

  • 1. GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E Protein.
    Clark MJ; Miduturu C; Schmidt AG; Zhu X; Pitts JD; Wang J; Potisopon S; Zhang J; Wojciechowski A; Hann Chu JJ; Gray NS; Yang PL
    Cell Chem Biol; 2016 Apr; 23(4):443-52. PubMed ID: 27105280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
    Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
    Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
    ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
    Anasir MI; Ramanathan B; Poh CL
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
    Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
    PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
    Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.
    Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB
    ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drug discovery: Pyrimidine entry inhibitors for Zika and dengue viruses.
    Gallo FN; Marquez AB; Fidalgo DM; Dana A; Dellarole M; García CC; Bollini M
    Eur J Med Chem; 2024 Jun; 272():116465. PubMed ID: 38718623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site.
    Fabbro D; Manley PW; Jahnke W; Liebetanz J; Szyttenholm A; Fendrich G; Strauss A; Zhang J; Gray NS; Adrian F; Warmuth M; Pelle X; Grotzfeld R; Berst F; Marzinzik A; Cowan-Jacob SW; Furet P; Mestan J
    Biochim Biophys Acta; 2010 Mar; 1804(3):454-62. PubMed ID: 20152788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the allosteric inhibition of Abl kinase.
    Fallacara AL; Tintori C; Radi M; Schenone S; Botta M
    J Chem Inf Model; 2014 May; 54(5):1325-38. PubMed ID: 24787133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK.
    Hutterer C; Wandinger SK; Wagner S; Müller R; Stamminger T; Zeitträger I; Godl K; Baumgartner R; Strobl S; Marschall M
    Antiviral Res; 2013 Aug; 99(2):139-48. PubMed ID: 23648710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopes based drug design for dengue virus envelope protein: A computational approach.
    Wadood A; Mehmood A; Khan H; Ilyas M; Ahmad A; Alarjah M; Abu-Izneid T
    Comput Biol Chem; 2017 Dec; 71():152-160. PubMed ID: 29096381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2.
    de la Guardia C; Stephens DE; Dang HT; Quijada M; Larionov OV; Lleonart R
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29547522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase.
    Martinez-Gualda B; Pu SY; Froeyen M; Herdewijn P; Einav S; De Jonghe S
    Bioorg Med Chem; 2020 Jan; 28(1):115188. PubMed ID: 31757682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small molecule fusion inhibitor of dengue virus.
    Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyrazolo[3,4-d]pyrimidines as dual Src-Abl inhibitors active against mutant form of Abl and the leukemia K-562 cell line.
    El-Moghazy SM; George RF; Osman EEA; Elbatrawy AA; Kissova M; Colombo A; Crespan E; Maga G
    Eur J Med Chem; 2016 Nov; 123():1-13. PubMed ID: 27474918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn Kinases.
    Vincetti P; Caporuscio F; Kaptein S; Gioiello A; Mancino V; Suzuki Y; Yamamoto N; Crespan E; Lossani A; Maga G; Rastelli G; Castagnolo D; Neyts J; Leyssen P; Costantino G; Radi M
    J Med Chem; 2015 Jun; 58(12):4964-75. PubMed ID: 26039671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small-molecule dengue virus entry inhibitor.
    Wang QY; Patel SJ; Vangrevelinghe E; Xu HY; Rao R; Jaber D; Schul W; Gu F; Heudi O; Ma NL; Poh MK; Phong WY; Keller TH; Jacoby E; Vasudevan SG
    Antimicrob Agents Chemother; 2009 May; 53(5):1823-31. PubMed ID: 19223625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.